You can view the latest news of the Company.
 
Select Another Company
 
Market Cap. (Rs.) 1727.85 Cr. P/BV 2.34 Book Value (Rs.) 315.32
52 Week High/Low (Rs.) 1222/621 FV/ML 10/1 P/E(X) 302.48
Bookclosure 20/09/2024 EPS (Rs.) 2.44 Div Yield (%) 0.14
Date and TimeHeadlines
09/05/2025 16:25 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Earni...
09/05/2025 16:24 Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Cal...
05/05/2025 19:17 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analy...
05/05/2025 19:16 Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Cal...
05/05/2025 14:58 Tatva Chintan Pharm - Investor Presentation
05/05/2025 14:58 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Inves...
05/05/2025 14:51 Tatva Chintan Pharm - Bagging/Receiving of orders/contracts
05/05/2025 14:51 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Award...
03/05/2025 14:41 Tatva Chintan Pharm - Copy of Newspaper Publication
02/05/2025 18:04 Tatva Chintan Pharm - Change in Directors/ Key Managerial Personnel...
02/05/2025 17:28 Tatva Chintan Pharm - Outcome of Board Meeting-XBRL
02/05/2025 17:20 Tatva Chintan Pharm - Audited Financial Results (Standalone And Con...
02/05/2025 17:13 Tatva Chintan Pharm - Appointment Of Secretarial Auditor, Cost Audi...
02/05/2025 17:10 Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Divid...
02/05/2025 17:08 Tatva Chintan Pharm - Corporate Action-Board approves Dividend
02/05/2025 17:06 Tatva Chintan Pharm - General Updates
02/05/2025 17:00 Tatva Chintan Pharm - Board Meeting Outcome for Outcome Of The Boar...
02/05/2025 16:54 Tatva Chintan Pharm - Dividend
02/05/2025 16:50 Tatva Chintan Pharm Q4 net profit down 86.67% at Rs 1.10 cr
02/05/2025 16:49 Tatva Chintan Pharm - Outcome of Board Meeting
12